PAVmed Inc. Balance Sheet
PAVM|5 years of annual SEC 10-K data (FY2021-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
PAVmed Inc. had $39M in total assets and $34M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1.5M | $1.2M | $19.6M | $39.7M | $77.3M |
| Accounts Receivable | - | $18.0K | $61.0K | $17.0K | $200.0K |
| Inventory | - | - | $278.0K | - | - |
| Current Assets | $2.6M | $2.2M | $24.5M | $43.9M | $82.6M |
| PP&E (Net) | $77.0K | $151.0K | $1.8M | $2.5M | $1.6M |
| Total Assets | $38.8M | $30.7M | $33.1M | $54.0M | $87.0M |
| Current Liabilities | $14.8M | $35.4M | $54.2M | $41.2M | - |
| Shareholders' Equity | $34.0M | -$2.5M | -$53.8M | -$9.7M | $61.7M |